All In Biotech

Drug Trial Radar · NCT06636656

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Phase IIa, Sequential Cohort, Open-label, Multi-center Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Induction and Subcutaneous Maintenance Treatment With BI 3032950 in Patients With Moderate to Severe Ulcerative Colitis

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Dec 11, 2024

Primary completion

Jul 30, 2027

Study completion Jul 30, 2029

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
First posted
Oct 15, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Adults between 18 and 80 years of age with ulcerative colitis can participate in this study. This is a study for people for whom previous treatment was not successful or who stopped previous treatment. The purpose of this study is to find out whether BI 3032950 helps people with ulcerative colitis. This study has 2 parts. In Part A, participants get BI 3032950 as an infusion into a vein every 4 weeks. After 12 weeks, doctors check whether the signs and symptoms of ulcerative colitis have improved. Before the results of this assessment are available, participants move on to Part B and get BI 3032950 as an injection under the skin. Participants whose results show clinical response after 12 weeks can continue treatment with BI 3032950. They get BI 3032950 injections under the skin every 4 weeks for up to 2 years. Participants visit their doctors every 4 weeks. During these visits, the doctors check the signs and symptoms of ulcerative colitis. This includes taking blood and stool samples. Doctors also do endoscopies. This is a procedure that uses a tube with a camera to look inside the body. The doctors also regularly check participants' health and take note of any unwanted effects.

Conditions

  • Ulcerative Colitis

Interventions

  • BI 3032950 intravenous (Part A)Drug

    BI 3032950 intravenous (Part A)

  • BI 3032950 subcutaneous (Part B)Drug

    BI 3032950 subcutaneous (Part B)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients with clinical remission defined by the modified Mayo Score [mSC] with mSC of 0 to 2, including stool frequency subscore [SFS] of 0 or 1, rectal bleeding subscore [RBS] of 0, and centrally-read endoscopy subscore [ESS] of 0 or 1Time frame: Up to Week 12

Locations

42 sites in 6 countries. Site status is shown where the registry gives one.

  • One of a Kind Clinical Research Center

    Scottsdale, Arizona · Not yet recruiting

  • Peak Gastroenterology Associates

    Colorado Springs, Colorado · Recruiting

  • Primary Care of Osceola

    Kissimmee, Florida · Recruiting

  • Florida Research Institute

    Lakewood Rch, Florida · Recruiting

  • University of Miami

    Miami, Florida · Recruiting

  • Reliant Medical Research

    Miami, Florida · Recruiting

  • Illinois Gastroenterology Group - Gurnee

    Gurnee, Illinois · Recruiting

  • University of Kansas Medical Center

    Kansas City, Kansas · Recruiting

  • Columbia University Medical Center

    New York, New York · Not yet recruiting

  • Atrium Health Gastroenterology and Hepatology

    Charlotte, North Carolina · Recruiting

  • Texas Digestive Disease Consultants

    Cedar Park, Texas · Recruiting

  • Baylor College of Medicine

    Houston, Texas · Recruiting

  • Tyler Research Institute, LLC

    Tyler, Texas · Not yet recruiting

  • University of Washington

    Seattle, Washington · Recruiting

  • Digestive Health Specialists

    Tacoma, Washington · Recruiting

  • UZ Leuven

    Leuven, Belgium · Recruiting

  • CHC MontLegia

    Liège, Belgium · Recruiting

  • Hepato-Gastroenterologie HK, s.r.o.

    Hradec Králové, Czechia · Not yet recruiting

  • ISCARE a.s.

    Prague, Czechia · Recruiting

  • Centrum Medyczne Plejady

    Krakow, Poland · Recruiting

  • Medrise Sp. z o.o.

    Lublin, Poland · Recruiting

  • Eskulap Pabianice Sp. z o.o.

    Pabianice, Poland · Recruiting

  • EMC Instytut Medyczny S.A. - Poznan 70-304

    Poznan, Poland · Recruiting

  • Clinical Research Center Sp. z o.o. Medic-R sp.k.

    Poznan, Poland · Recruiting

  • Centrum Medyczne Medyk Sp. z o.o.

    Rzeszów, Poland · Recruiting

  • Endoskopia Sp. z o.o.

    Sopot, Poland · Recruiting

  • Twoja Przychodnia Szczecinskie Centrum Medyczne Sp. z o.o.

    Szczecin, Poland · Recruiting

  • Gastromed Sp. z o.o.

    Torun, Poland · Recruiting

  • Synexus Polska Sp. z o.o.

    Warsaw, Poland · Recruiting

  • NZOZ VIVAMED Jadwiga Miecz

    Warsaw, Poland · Recruiting

  • Centrum Diagnostyczno Lecznicze Barska Sp. z o.o.

    Włocławek, Poland · Recruiting

  • PlanetMed Sp. z o.o.

    Wroclaw, Poland · Recruiting

  • EMC Instytut Medyczny S.A. - Wroclaw

    Wroclaw, Poland · Recruiting

  • Pro Life Medica Sp. z o.o.

    Zamość, Poland · Recruiting

  • Clinical Hospital Center Zvezdara

    Belgrade, Serbia · Recruiting

  • Military Medical Academy

    Belgrade, Serbia · Not yet recruiting

  • Clinical Center Zemun

    Belgrade, Serbia · Not yet recruiting

  • General Hospital - Djordje Joanovic

    Zrenjanin, Serbia · Recruiting

  • F D Roosevelt University General Hospital Of Banska Bystrica

    Banská Bystrica, Slovakia · Recruiting

  • ENDOMED s.r.o.

    Košice, Slovakia · Recruiting

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.